Blood Cancer J 10 (2): 22, 2020. doi: 10.1038 / s41408 - 020 - 0290 - 9 Prognosis for Polycythemia Vera Some studies cite a median survival of 24 years, but many patients live much longer, even when myelofibrosis develops.